Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

DIVIDEND DECLARATION & DIV TARGET '25(Replacement)

27 Jan 2025 18:15

RNS Number : 8572U
CVC Income & Growth Limited
27 January 2025
 

27 January 2025

 

CVC Income & Growth Limited

 

DIVIDEND DECLARATION & ANNUAL DIVIDEND TARGET '25 (Replacement)

 

The following amendment has been made to the announcement released on 24 January 2025 at 12:53hrs (RNS No. 6613U). In the second paragraph, the quarterly interim dividend per ordinary Euro share has been corrected from 2.486c to 2.0486c. All other details remain unchanged. The full amended text is shown below.

Dividend Declaration and

Annual Dividend Targets for financial year 2025

The information contained within this announcement constitutes inside information.

The Board of Directors of the Company has declared a quarterly interim dividend of 3.3038p per ordinary Sterling Share and 2.0486c per ordinary Euro Share.

These amounts reflect an uplift to the previously indicated quarterly dividend of 2.0625p per Sterling ordinary share and 1.8125c per Euro ordinary share announced by the Company on 30 January 2024.

The ex-dividend date will be 6 February 2025, with the dividends payable on 28 February 2025.

The Board of Directors, in conjunction with the Investment Vehicle Manager, has also completed its periodic review of the Company's annual dividend targets. As a consequence, the Company's annual dividend targets are 9.25p per ordinary Sterling Share (an increase of 1p above 2024) and 7.25c per ordinary Euro Share (unchanged from 2024) with from the first 2025 quarterly interim dividend. This means that the Company's quarterly dividends will be 2.3125p per Sterling Share and 1.8125c per Euro Share, including the Company's first quarter 2025 dividends, payable in the second quarter of 2025.

The Chairman of the Company, Robert Kirkby commented: "The Board of Directors continues to give detailed consideration, not only to the current cash yield of the Investment Vehicle's underlying portfolio by principal reference to its weighted average coupon, but also to market conditions including future trends in default rates and the direction of risk-free rates in the Investment Vehicle's chosen markets, given the Investment Vehicle's predominantly floating rate exposure. The Board is mindful that shareholders expect changes to dividend targets to be made on a sustainable basis, and thus, in the absence of significant and relevant unexpected macroeconomic or geopolitical events, the Company's annual dividend targets should not be changed for at least the next 12 months."

Mr Kirkby added "The Board of Directors also wishes to reconfirm that, in the event that the Investment Vehicle portfolio produces surplus cash income beyond that currently anticipated, an upwards only adjustment will, if appropriate, be made to the Company's fourth quarter 2025 dividends payable in the first quarter of 2026, in a manner similar to that recently announced in respect of the fourth quarter of 2024. There should be no expectation as to the level of any such adjustments or indeed whether such adjustments will arise at all."

The person responsible for arranging for the release of this announcement on behalf of the Company is Sharon A Williams of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPFXAFFSEFA
Date   Source Headline
29th Apr 20254:50 pmRNSResult of AGM
28th Apr 20254:03 pmRNSIssue of Equity
25th Apr 20259:35 amRNSNet Asset Value Weekly to 17 Apr 2025
24th Apr 20255:49 pmRNSIssue of Equity
23rd Apr 20253:27 pmRNSMONTHLY REPORT
23rd Apr 202511:50 amRNSNet Asset Value Weekly to 11 Apr 2025
22nd Apr 202511:37 amRNSMarch 2025 Tender Price
11th Apr 20254:49 pmRNSNotice of 2025 Annual General Meeting
10th Apr 20254:05 pmRNSNet Asset Value Weekly to 04 Apr 2025
7th Apr 20253:53 pmRNSDirector/PDMR Shareholding
7th Apr 202511:42 amRNSDirector/PDMR Shareholding
2nd Apr 20256:10 pmRNSNet Asset Value Weekly to 28 Mar 2025
1st Apr 202511:34 amRNSTotal Voting Rights
27th Mar 20253:12 pmRNSIssue of Equity
27th Mar 20252:45 pmRNSNet Asset Value Weekly to 21 Mar 2025
27th Mar 20257:00 amRNS2024 Annual Report and Financial Statements
25th Mar 20254:06 pmRNSIssue of Equity
20th Mar 20253:30 pmRNSNet Asset Value Weekly to 14 Mar 2025
19th Mar 202511:17 amRNSMONTHLY REPORT
19th Mar 202511:07 amRNSIssue of Equity
14th Mar 202510:16 amRNSNet Asset Value Month End 28 Feb 2025
13th Mar 20251:50 pmRNSNet Asset Value Weekly to 07 Mar 2025
12th Mar 20253:13 pmRNSIssue of Equity
10th Mar 202512:11 pmRNSIssue of Equity
6th Mar 20254:35 pmRNSNet Asset Value Weekly to 28 Feb 2025
6th Mar 202510:43 amRNSRESULTS OF PLACINGS FOR MARCH 2025 TENDER
3rd Mar 20254:55 pmRNSTotal Voting Rights
3rd Mar 20254:06 pmRNSIssue of Equity
27th Feb 202512:35 pmRNSNet Asset Value Weekly to 21 Feb 2025
27th Feb 202510:55 amRNSIssue of Equity
26th Feb 20253:36 pmRNSIssue of Equity
26th Feb 20259:37 amRNSMONTHLY REPORT
21st Feb 20255:09 pmRNSNet Asset Value Weekly to 14 Feb 2025
18th Feb 20259:01 amRNSNet Asset Value Month End 31 Jan 2025
14th Feb 20255:27 pmRNSResult of March 25 Tender Process (Replacement)
14th Feb 20252:38 pmRNSResult of March 2025 Semi-Annual Tender Process
14th Feb 20251:50 pmRNSNet Asset Value Weekly to 07 Feb 2025
14th Feb 202510:29 amRNSIssue of Equity
13th Feb 20254:58 pmRNSIssue of Equity
11th Feb 202511:54 amRNSDirector/PDMR Shareholding
11th Feb 20259:47 amRNSHolding(s) in Company
6th Feb 20255:10 pmRNSNet Asset Value Weekly to 31 Jan 2025
6th Feb 20251:32 pmRNSIssue of Equity
5th Feb 20254:36 pmRNSIssue of Equity
5th Feb 20253:58 pmRNSDirector/PDMR Shareholding
4th Feb 20253:10 pmRNSHolding(s) in Company
4th Feb 202510:01 amRNSHolding(s) in Company
3rd Feb 20254:58 pmRNSTotal Voting Rights
31st Jan 202510:11 amRNSNet Asset Value Weekly to 24 Jan 2025
30th Jan 20255:14 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.